Study identifier:D853AC00001
ClinicalTrials.gov identifier:NCT06767462
EudraCT identifier:N/A
CTIS identifier:2024-512161-14-00
A Multicentre Study Assessing Ophthalmic Safety in Patients with Breast Cancer
Ophthalmic Safety in Patients with Breast Cancer
Phase 1
No
-
All
160
Observational
18 Years - 130 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: -
Primary Purpose: Other
Verified 01 Jan 2025 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Cohort 1 from Qualifying Study | - |
Cohort 2 from Qualifying Study | - |